BILL ANALYSIS                                                                                                                                                                                                    



                                                                  SB 472
                                                                  Page  1

          Date of Hearing:   July 3, 2007

                   ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
                                   Mike Eng, Chair
                    SB 472 (Corbett) - As Amended:  June 20, 2007

           SENATE VOTE  :   27-10
           
          SUBJECT  :   Prescription drugs:  labeling requirements.

           SUMMARY  :   Requires the Board of Pharmacy to promulgate  
          regulations that require a standardized, patient-centered,  
          prescription drug label on all prescription medication dispensed  
          to patients in California.  Specifically,  this bill  :   

          1)Requires the Board of Pharmacy to do all of the following:

             a)   Promulgate regulations that require, on or before  
               January 1, 2011, a standardized, patient-centered,  
               prescription drug label on all  prescription medicine  
               dispensed to patients in California;

             b)   Hold public meetings statewide, that are separate from  
               its normally scheduled hearings, in order to seek  
               information from groups representing consumers, seniors,  
               pharmacists or the practice of pharmacy, other health care  
               professionals, and other interested parties;

             c)   Consider all of the following factors when developing  
               the requirements for prescription drug labels:
               i)     Medical literacy research that points to increased  
                 understandability of labels;
               ii)    Improved directions for use;
               iii)   Improved font types and sizes;
               iv)    Placement of information that is patient-centered;
               v)     The needs of those patients with limited English  
                 proficiency;
               vi)    The needs of seniors; and,
               vii)   Technology requirements necessary to implement the  
                 standards;

             d)   Report to the Legislature by January 1, 2010, on its  
               progress under this bill; and,

             e)   Report to the Legislature by January 1, 2013, the status  








                                                                  SB 472
                                                                  Page  2

               of implementation of the prescription drug label  
               requirements adopted pursuant to this bill.

          2)Makes various findings related to the cost and use of  
            prescription drugs and the need to reduce medication-related  
            errors.

           EXISTING LAW  : 

          1)Establishes the Pharmacy Law, which provides for the  
            licensing, regulation and enforcement of the practice of  
            pharmacy by the Board of Pharmacy.  Makes it a misdemeanor to  
            violate the Pharmacy Law.

          2)Requires dispensed prescription drugs to be correctly labeled  
            with all of the following:
             a)   The trade name of the drug or the generic name and the  
               name of the manufacturer;
             b)   The directions for the use of the drug;
             c)   The name of the patient;
             d)   The name of the prescriber;
             e)   The date of issue;
             f)   The name and address of the pharmacy, and the  
               prescription number;
             g)   The strength of the drug;
             h)   The quantity of the drug or drugs dispensed;
             i)   The expiration date of the effectiveness of the drug;
             j)   The condition for which the drug was prescribed if  
               requested by the patient and if the condition is indicated  
               on the prescription; and,
             aa)  The physical description of the drug, including its  
               color, shape, and any identification code that appears on  
               the tablets or capsules, except as specified.

           FISCAL EFFECT  :   Unknown

           COMMENTS  :   

           Purpose of this bill  .  According to the author's office, this  
          bill is necessary to make prescription drug labels easy to  
          understand.  The author cites a number of reports as evidence of  
          the need for this bill.  According to the Institute of Medicine,  
          medication errors are among the most common medical errors,  
          harming at least 1.5 million people annually. An article in the  
          Journal of the American Medical Association states that 46% of  








                                                                  SB 472
                                                                  Page  3

          adults cannot understand the information on the label of their  
          pill bottles.  A 2006 Annals of Internal Medicine study found  
          that although 70.7% of patients with low literacy could  
          correctly repeat dosing instructions, only 34.7% could  
          demonstrate the correct number of pills to be taken daily.   
          Families USA reports that 40% of medications are taken  
          incorrectly by Medicare patients.  According to the 2005 U.S.  
          Census, more than one in five Californians speak English "less  
          than very well."  Separate studies show that limited English  
          proficient patients have a harder time understanding the  
          information on their prescription drug labels and have lower  
          levels of adhering to their medication regimens.  For all these  
          reasons, the author believes that standardized prescription drug  
          labels would facilitate patient understanding of the information  
          contained on these labels.

           Background .  In March 2007, the Medication Errors Panel (Panel),  
          established pursuant to SCR 49 (Speier), Resolution Chapter 123,  
          Statutes 2005, published its report, Prescription for Improving  
          Patient Safety: Addressing Medication Errors.  The report listed  
          six general goals to reduce medication errors.  Under each goal  
          were recommendations (twelve in all) and methods to accomplish  
          each recommendation.  The goal relevant to the subject matter of  
          this bill is: "Improve prescriber-pharmacist and  
          pharmacist-consumer communications to enhance understanding of  
          the intended use of prescribed medication."  To accomplish this  
          goal, the panel recommended the California Board of Pharmacy and  
          Medical Board of California pursue statutory and regulatory  
          changes that would require that the intended use of the  
          medication be included on all prescriptions and require that the  
          intended use of medication be included on medication  
          label/labeling unless disapproved by the prescriber or the  
          patient.

          The Panel report also stated that "the information that  
          consumers need to know about their medication is often complex  
          and may include unfamiliar language or concepts.  Expecting a  
          consumer to retain all the pertinent knowledge from a brief  
          verbal encounter may not be reasonable in many instances."  The  
          report cited the importance of consumers having written  
          information regarding their prescription.  However, the report  
          also stated that this information can be forgotten and lost, and  
          in those instances, consumers may be left with nothing more than  
          the prescription packaging and label to guide them.  Testimony  
          provided to the Panel identified many limitations related to the  








                                                                  SB 472
                                                                  Page  4

          prescription label as an effective communication tool. These  
          included the limited size of a prescription label (approximately  
          2 x 3 inches) which, due to established pharmacy systems,  
          processes, and drug container variability, would be functionally  
          and financially difficult for the pharmacy industry to change.   
          Further complicating matters is the fact that there is already a  
          significant amount of information required by California law to  
          be printed on the label.  The most recent label requirement went  
          into effect on January 1, 2006, and was created to help  
          consumers identify erroneously filled prescriptions by mandating  
          that pharmacies include the physical description of the  
          dispensed medication, including its color, shape, and any  
          identification code that appears on the tablets or capsules.   
          This bill will require a comprehensive review of prescription  
          label requirements and implementation of changes that will  
          provide consumers with elements of the most valuable pieces of  
          information

           Support  .  Proponents state that prescription medications are an  
          essential part of health care and contribute to increasing both  
          quality and life expectancy of patients, but despite their  
          importance, many Californians face challenges understanding and  
          complying with their medication regimen.  All too often, medical  
          errors have dire consequences.  In fact, proponents argue,  
          medication errors are a leading cause for hospitalizations in  
          the United States.  Proponents further suggest that national  
          trends are moving toward improving the readability of  
          prescription labels.  They state that Target Pharmacy has  
          created the ClearRX system to reduce medication errors, and  
          Walgreen's Pharmacy produces labels in more than 10 languages,  
          indicating that standardization and translation are realistic  
          goals for California.

           Opposition  .  The California Alliance for Consumer Protection  
          opposes this bill because it believes the Rx Cannabis industry  
          does not feel labels should be required on cannabis  
          prescriptions, but this bill's labeling requirements should  
          apply to sample prescription drugs.  

           Related legislation  .  AB 1276 (Karnette) of 2007, which would  
          have required prescribers of medications to ask patients whether  
          or not to indicate the intended purpose of the prescription on  
          the prescription's label, failed passage in the Assembly  
          Business and Professions Committee.









                                                                  SB 472
                                                                  Page  5

           REGISTERED SUPPORT / OPPOSITION  :

           Support 
           
          Latino Coalition for a Healthy California (sponsor)
          Gray Panthers California (sponsor)
          Senior Action Network (sponsor)
          California State Board of Pharmacy
          AIDS Healthcare Foundation
          American Federation of State, County and Municipal Employees
          Applied Research Center
          Asian Pacific American Legal Center of Southern California
          California Alliance for Retired Americans
          California Association of Public Authorities for In- Supportive  
          Services
          California Medical Association
          Latino Health Alliance
          Mexican American Legal Defense and Education Fund
          Pharmacist's Planning Service, Inc.
          Southern California HIV Advocacy Coalition
           
            Opposition 
           
          The California Alliance for Consumer Protection
           

           
           Analysis Prepared by  :    Ross Warren / B. & P. / (916) 319-3301